Live Breaking News & Updates on Impel Neuropharma Inc|Page 6

Stay updated with breaking news from Impel neuropharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

"The Buzz" Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment

"The Buzz" Show: Impel NeuroPharma, Inc. (NASDAQ: IMPL) FDA Approval for Acute Migraine Treatment
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

United States , Impel Neuropharma Inc , Buzz Show , Featuring Our Corporate News Recap , Acute Migraine , Precision Olfactory Delivery , Impel Neuropharma ,

FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine

FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United States , Thomas Jefferson University , Stephaniej Nahas Geiger , Adrian Adams , Kevin Lenaburg , Coalition For Headache , Impel Neuropharma Inc , Department Of Neurology , Drug Administration , Medscape Medical News , Migraine Patients , Impel Neuropharma ,

This analyst raised price target on Impel NeuroPharma by more than 50%

This analyst raised price target on Impel NeuroPharma by more than 50%
invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.

United States , Nasdaq Stock Exchange , Impel Neuropharma Inc , Migraine Research Foundation , Impel Neuropharma , Ken Cacciatore ,